This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sheikh, M. A Articles by Deitcher, S. R Search for Related Content PubMed PubMed Citation Articles by Sheikh, M. A Articles by Deitcher, S. R Social Bookmarking                   What's this?

Isolated internal jugular vein thrombosis: risk factors and natural history

Section of Vascular Medicine, Department of Cardiovascular Medicine and Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA

Arthur P Topoulos

Section of Vascular Medicine, Department of Cardiovascular Medicine and Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA

Steven R Deitcher

Section of Vascular Medicine, Department of Cardiovascular Medicine and Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA

Deep venous thrombosis (DVT) involving the upper extremities, chest, and neck has become appreciated as a significant cause of morbidity, especially in individuals with central venous access devices (CVAD). Like DVT involving the leg and pelvic veins, axillo-subclavian vein thrombosis can result in pulmonary embolism, post-thrombotic syndrome, and venous limb gangrene. Data relating to the natural history of internal jugular vein thrombosis (IJVT) is lacking. Risk factors, treatment patterns, and clinically relevant outcomes were retrospectively assessed in 74 consecutive patients with isolated IJVT. All patients (median age 66 years; range 36-80) had CVAD-associated IJVT, 22 (29.7%) had a history of cancer, and 14 (18.9%) had a history of prior DVT. Thirty-two (43.2%) were treated with systemic anticoagulation, 2 (2.7%) received a superior vena cava filter, and 40 (54.1%) received no specific therapy. Of the patients who underwent serial imaging, 7/40 (17.5%) had thrombus propagation. Two (2.7%) patients were diagnosed with pulmonary embolism, 8 (10.8%) were diagnosed with malignancy during a median follow-up of 20 months (range 18-24), and 3/53 (5.7%) suffered a recurrent DVT. Outcomes similar to those seen in leg DVT were observed. The most effective treatment strategy remains to be determined, but anticoagulant treatment was associated with a trend towards reduced all-cause mortality.

Key Words: cancer • deep venous thrombosis • jugular vein • pulmonary embolism • thrombosis • venous access

Vascular Medicine, Vol. 7, No. 3, 177-179 (2002)
DOI: 10.1191/1358863x02vm440oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. W. Knott, S. D. Cassivi, and P. Gloviczki Open Central Venous Reconstruction: Technique, Advantages, and Pitfalls of Partial Sternotomy With Infraclavicular Resection of the First Rib Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2008; 20(2): 214 - 219. [Abstract] [PDF]

				H. Tajima, S. Murata, T. Kumazaki, K. Ichikawa, T. Tajiri, and Y. Yamamoto Successful Interventional Treatment of Acute Internal Jugular Vein Thrombosis Am. J. Roentgenol., February 1, 2004; 182(2): 467 - 469. [Full Text] [PDF]